UNSPSC 51101923: Atovaquone

This classification denotes an antimalarial and anti-infective agent with the molecular formula C22H19ClO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y883P1Z2LT, chemically known as 1,4-naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy- but generally known as atovaquone, which bears US NIH Compound Identifier 74989. Atovaquone most often comes in base form and is sometimes combined with proguanil.

UNSPSC 51101923 Atovaquone, a Commodity code, nominally describes pharmaceutical procurement but shows minimal recent state and local activity directly aligned with the drug itself. The most recent opportunities tagged to this code involve broader pharmaceutical and medical supply purchasing — generic pharmaceuticals, over-the-counter products, naloxone, and medical/first-aid supplies — suggesting state and local procurement offices use this code as a catch-all for pharmaceutical procurement rather than tracking atovaquone as a line-item purchase. The work being solicited includes standing supply contracts for generic and OTC pharmaceuticals distributed through cooperative purchasing alliances and wholesalers, direct-to-manufacturer prescription programs, emergency medical supplies for fire rescue operations, and community health naloxone procurement. Issuing bodies include state health and human services departments, cooperative purchasing alliances serving multiple states and localities, county health departments, and municipal fire departments. The mix reflects a combination of statewide procurement operations, regional cooperative purchasing vehicles, and local emergency services operations.

Recent opportunities span Texas, Minnesota (serving multistate participation including Oregon), Florida, and local procurement in Tampa, with the most substantial recent activity in the Texas Health and Human Services Commission's Therapeutic Pharmacy Initiative RFI (HHS0017013, due April 3, 2026) and the Minnesota Multistate Cooperative Purchasing Alliance's generic pharmaceuticals and OTC products RFP (S1070000015802, due March 26, 2026) serving state and local government facilities. The City of Tampa's medical and first aid supplies IFB (26P00145) designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount, closed March 13, 2026, with an estimated contract value of $700,000.00. Seminole County, Florida's naloxone and drug deactivation systems procurement (IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries. The code shows activity concentrated in state health department procurement, cooperative purchasing alliances, and emergency services, with limited evidence of atovaquone as a standalone purchasing driver.